Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report

We present the first evidence that sub-anesthetic ketamine infusions for treatment resistant depression (TRD) may facilitate deprescription of long-term benzodiazepine/z-drugs (BZDRs). Long-term BZDR prescriptions are potentially harmful yet common, partly because of challenging withdrawal symptoms....

Descripción completa

Detalles Bibliográficos
Autores principales: Garel, Nicolas, Greenway, Kyle T., Dinh-Williams, Lê-Anh L., Thibault-Levesque, Julien, Jutras-Aswad, Didier, Turecki, Gustavo, Rej, Soham, Richard-Devantoy, Stephane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579413/
https://www.ncbi.nlm.nih.gov/pubmed/37532888
http://dx.doi.org/10.1038/s41386-023-01689-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579413/
https://www.ncbi.nlm.nih.gov/pubmed/37532888
http://dx.doi.org/10.1038/s41386-023-01689-y

Ejemplares similares